TM
About Us
Unlocking human potential with mammary biotechnology.
Company History
2009
Leila, our CEO, experienced the difficulties of breastfeeding. At the same time, she was finishing her post-doc using cell culture to model other aspects of human physiology; the idea to make milk outside the body was born.
Leila with her son Levi, 2009
2020
Leila co-founded BIOMILQ in January of 2020. Six months later, they closed a seed round of $3.5M led by Breakthrough Energy Ventures (BEV).
2021
BIOMILQ began to build out its team. They closed a Series A funding round at $21M, co-led by Novo Holdings and BEV, and soon after moved into a larger facility that can support rigorous bioprocess and cell line development.
2022
BIOMILQ developed the world’s most productive proprietary mammary cell bank by completing an IRB-approved research study, where over 300 women of all backgrounds and stages of lactation donated their breast milk.
2023
BIOMILQ developed multiple optimized cell lines for production and validated their system’s unmatched potential. Additionally, they developed strong strategic partnerships and made crucial steps towards scaling and optimizing their bioprocess.
BIOMILQ Scientist, 2022, photo by CNN
BIOMILQ at a glance
$24.5M capital raised
from industry leading investors
25 team members
with expertise in human milk, cell line development, and engineering
5 patents
with 38 pending applications, across 13 markets
60+ cell donors
from women of all backgrounds and stages of lactation
6+ cell lines
optimized for target production of human milk components
Leading HMO program
poised for impact
& a versatile platform to produce various milk components
Transforming lactation research
Human milk is incredible! It is the optimal source of nutrition for babies, and there is enormous potential to expand upon its capabilities to impact human health beyond birth.
​
Human milk and lactation research has historically been underfunded and understudied, which is unfortunately the case for all women's health research.
BIOMILQ has a breast milk bank from more than 300 women who donated their milk during an IRB-approved research study. BIOMILQ is utilizing these donations to conduct research on the intricate composition of human milk and its nutritional and functional components.
​
We are rooted in science and deeply committed to the discovery and development of research that will transform the human milk and lactation space.
Awards and Recognitions
